Hormonal drug degarelix approved for treating advanced prostate cancer.(NEWS FROM THE FDA): An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2009. The length of the article is 569 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Hormonal drug degarelix approved for treating advanced prostate cancer.(NEWS FROM THE FDA)
Author: Betsy Bates
Publication:Internal Medicine News (Magazine/Journal)
Date: January 15, 2009
Publisher: International Medical News Group
Volume: 42 Issue: 2 Page: 4(1)

Distributed by Gale, a part of Cengage Learning